These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
718 related items for PubMed ID: 28460475
1. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling. Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F. Oncotarget; 2017 Apr 18; 8(16):26927-26940. PubMed ID: 28460475 [Abstract] [Full Text] [Related]
2. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells. Song JM, Im J, Nho RS, Han YH, Upadhyaya P, Kassie F. Mol Carcinog; 2019 Mar 18; 58(3):321-333. PubMed ID: 30365189 [Abstract] [Full Text] [Related]
3. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin. Matou-Nasri S, Gaffney J, Kumar S, Slevin M. Int J Oncol; 2009 Oct 18; 35(4):761-73. PubMed ID: 19724912 [Abstract] [Full Text] [Related]
4. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder. Niedworok C, Kretschmer I, Röck K, Vom Dorp F, Szarvas T, Heß J, Freudenberger T, Melchior-Becker A, Rübben H, Fischer JW. PLoS One; 2013 Oct 18; 8(9):e75681. PubMed ID: 24069434 [Abstract] [Full Text] [Related]
5. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL). Oldenburg D, Ru Y, Weinhaus B, Cash S, Theodorescu D, Guin S. BMC Cancer; 2016 Sep 05; 16(1):713. PubMed ID: 27595989 [Abstract] [Full Text] [Related]
6. Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway. Li M, Jin S, Cao Y, Xu J, Zhu S, Li Z. Cancer Cell Int; 2021 Jan 06; 21(1):19. PubMed ID: 33407495 [Abstract] [Full Text] [Related]
7. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells. Nagase H, Kudo D, Suto A, Yoshida E, Suto S, Negishi M, Kakizaki I, Hakamada K. Pancreas; 2017 Feb 06; 46(2):190-197. PubMed ID: 27846148 [Abstract] [Full Text] [Related]
9. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway. Wang J, Zhang Z, Li R, Sun W, Chen J, Zhang H, Shu K, Lei T. Life Sci; 2018 Feb 01; 194():150-156. PubMed ID: 29288766 [Abstract] [Full Text] [Related]
10. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21. Li X, Zang A, Jia Y, Zhang J, Fan W, Feng J, Duan M, Zhang L, Huo R, Jiao J, Zhu X. Mol Med Rep; 2016 Mar 01; 13(3):2763-8. PubMed ID: 26847601 [Abstract] [Full Text] [Related]
11. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis. Leng Y, Abdullah A, Wendt MK, Calve S. Matrix Biol; 2019 May 01; 78-79():236-254. PubMed ID: 30130585 [Abstract] [Full Text] [Related]
12. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR. Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N. Lab Invest; 2011 Mar 01; 91(3):379-91. PubMed ID: 20956971 [Abstract] [Full Text] [Related]
13. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition. Deng QD, Lei XP, Zhong YH, Chen MS, Ke YY, Li Z, Chen J, Huang LJ, Zhang Y, Liang L, Lin ZX, Liu Q, Li SP, Yu XY. Acta Pharmacol Sin; 2021 Sep 01; 42(9):1486-1497. PubMed ID: 33893396 [Abstract] [Full Text] [Related]
14. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells. Mao X, Tong J, Wang Y, Zhu Z, Yin Y, Wang Y. Mol Med Rep; 2018 Sep 01; 18(3):3041-3049. PubMed ID: 30015908 [Abstract] [Full Text] [Related]
15. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Karousou E, Misra S, Ghatak S, Dobra K, Götte M, Vigetti D, Passi A, Karamanos NK, Skandalis SS. Matrix Biol; 2017 May 01; 59():3-22. PubMed ID: 27746219 [Abstract] [Full Text] [Related]
16. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer. Xiong J, Su T, Qu Z, Yang Q, Wang Y, Li J, Zhou S. Oncotarget; 2016 Apr 26; 7(17):23933-46. PubMed ID: 27004407 [Abstract] [Full Text] [Related]
17. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer. Reno TA, Tong SW, Wu J, Fidler JM, Nelson R, Kim JY, Raz DJ. BMC Cancer; 2016 Jul 11; 16():439. PubMed ID: 27400883 [Abstract] [Full Text] [Related]
18. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells. Jiang C, Fang X, Zhang H, Wang X, Li M, Jiang W, Tian F, Zhu L, Bian Z. Biomed Pharmacother; 2017 Feb 11; 86():677-685. PubMed ID: 28038429 [Abstract] [Full Text] [Related]
19. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan. Carvalho AM, Soares da Costa D, Reis RL, Pashkuleva I. Acta Biomater; 2022 Jul 01; 146():187-196. PubMed ID: 35577044 [Abstract] [Full Text] [Related]
20. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis. Reno TA, Kim JY, Raz DJ. Ann Thorac Surg; 2015 Nov 01; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]